CARD19

Caspase recruitment domain-containing protein 19 · Q96LW7 · CARD19 on Sugi Atlas →

0 patent compounds predicted against CARD19, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CARD19 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease PHASE4COMPLETED
Disulfiram in Rheumatoid Arthritis PHASE2NOT_YET_RECRUITING
Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment EARLY_PHASE1UNKNOWN
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases nanUNKNOWN
Inflammasomes in Cell Death in FTMH, ERM, and RRD nanCOMPLETED
Evaluation of Inflammasome Gene Polymorphisms in Periodontitis Patients nanUNKNOWN
Nucleotide Protein -3 in Epileptic Children nanUNKNOWN
Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk nanWITHDRAWN
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease nanWITHDRAWN
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
Role NLRP3 Inflammasome in Weight Loss Following Sleeve Gastrectomy in Morbidly Obese Patients nanUNKNOWN
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Role of Type 2 Diabetes in Potentiating the Inflammatory Response Post Extracorporeal Circulation After Cardiac Surgery nanWITHDRAWN
Gluten-related Disorders in Familial Mediterranean Fever Patients nanCOMPLETED
Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis nanCOMPLETED
TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients nanACTIVE_NOT_RECRUITING
Infectious Agents in Pediatric Crohn's nanCOMPLETED
RNA Cloning and Visualization in Human Atherosclerosis nanCOMPLETED
Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa nanCOMPLETED
Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer. nanUNKNOWN
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases) nanRECRUITING
Study of the Sex Differences in Inflammatory Diseases in Children nanUNKNOWN
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia nanRECRUITING
Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient nanRECRUITING
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
The T Cell Activator of Cell Killing (TACK) IT ON STUDY nanRECRUITING
Effect of Low Dose of Colchicine on Platelet Reactivity nanCOMPLETED
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a CARD19 binder may also engage these)

ProteinNameSimilarity
Q68UT4 0.958 Q68UT4 →
Q8NFT6 0.955 Q8NFT6 →
Q5EG05 0.951 Q5EG05 →
Q5VUJ9 0.951 Q5VUJ9 →
Q9D159 0.948 Q9D159 →
Q96HA4 0.948 Q96HA4 →
Q8TCY5 0.948 Q8TCY5 →
Q3UIW8 0.945 Q3UIW8 →
Q9BT76 0.944 Q9BT76 →
Q5FW56 0.944 Q5FW56 →
Q9QZA1 0.944 Q9QZA1 →
Q9D1I2 0.944 Q9D1I2 →
Q96ET8 0.944 Q96ET8 →
Q27969 0.943 Q27969 →
Q5MJ68 0.942 Q5MJ68 →
Q62392 0.942 Q62392 →
Q6IPT2 0.941 Q6IPT2 →
Q5PPH4 0.941 Q5PPH4 →
Q8WV24 0.940 Q8WV24 →
Q01113 0.940 Q01113 →
A2AGX3 0.940 A2AGX3 →
P50745 0.937 P50745 →
Q9H607 0.936 Q9H607 →
Q9P2E8 0.936 Q9P2E8 →
Q8C4U2 0.935 Q8C4U2 →
Q9UIL1 0.935 Q9UIL1 →
Q9DCK4 0.935 Q9DCK4 →
Q6AZ51 0.935 Q6AZ51 →
Q9BZ19 0.935 Q9BZ19 →
Q58D91 0.935 Q58D91 →